Companies: 10,795·Total market cap: $144.5T
Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation

AGTCNASDAQHealthcare
$0.39
+$0.00(+0.00%)
Market Cap$0
P/E Ratio
52W High$2.825
52W Low$0.2303
Overview

Applied Genetic Technologies Corporation (AGTC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AGTC · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.93agtc eps ttm · agtc earnings per shareEarnings history
PE Ratio (TTM)agtc pe ratio ttm · agtc price to earningsPE Ratio deep dive
Revenue (TTM)325000.00agtc revenue ttm · agtc annual revenueFull revenue history
Dividend YieldNo Dividenddoes agtc pay dividends · agtc dividend yieldDividend history
Shares Outstanding45.0Magtc shares outstanding · agtc floatShares outstanding history
Next EarningsTBAagtc earnings date · agtc next earningsEarnings history

Financial Snapshot

Full Financials
FY 2022Revenue$325000.00▼ 35.00% YoY
202020212022
applied genetic technologies corporation revenue · agtc revenue 2022
FY 2022Net Income-$71.4M▼ 23.51% YoY
202020212022
applied genetic technologies corporation net income · agtc profit 2022
FY 2022EPS$-1.59▲ +10.17% YoY
202020212022
agtc eps · applied genetic technologies corporation earnings per share 2022
TTM:Revenue: $325000.00Net Income: -$35.3MEPS: $-0.93View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy14 analystsis agtc a buy · agtc analyst rating
Strong Buy
0
Buy
9
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.39Current
$Avg Target
$High
agtc price target · agtc 12 month forecast

Total: 14 · Buy rate: 64.3%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M-2.74%
YTD+0.00%
1Y-83.93%
5Y-89.78%

About Applied Genetic Technologies Corporation

CEOSusan Washer
IPO DateMar 27, 2014
Employees102
CountryUS
Websiteagtc.com

Applied Genetic Technologies Corporation (AGTC) is a clinical-stage biotechnology company focused on developing innovative genetic therapies aimed at transforming the lives of patients battling rare a…

what is applied genetic technologies corporation · agtc stock overview · applied genetic technologies corporation company profile · who is applied genetic technologies corporation ceo · agtc NASDAQ · applied genetic technologies corporation headquarters · applied genetic technologies corporation business segments

About Stock Overview & Key Data

Applied Genetic Technologies Corporation (AGTC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 27, 2014. As of the latest trading session, AGTC stock price is $0.39, with a market capitalization of $0. The stock has returned -83.93% over the past 12 months and +0.00% year-to-date.

According to 14 Wall Street analysts, the consensus rating for Applied Genetic Technologies Corporation stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Applied Genetic Technologies Corporation reported revenue of $325000.00 and net income of -$71.4M. For detailed data — including Applied Genetic Technologies Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Applied Genetic Technologies Corporation (AGTC) stock price is $0.39. The stock is traded on NASDAQ under the ticker symbol AGTC. The 52-week range is $0.23 – $2.83.

AGTC stock priceAGTC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice